logo

For the Inventor, By the Inventor

Paramus, NJ, United States of America

Pgi Drug Discovery LLC


USPTO Granted Patents = 16

% Expired Patents = 18.8


Trademarks = 4

Forward Citations = 41

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Taleen G Hanania (14 out of 15 patents)

silverMedal Linghong Xie (8 out of 13 patents)

bronzeMedal John Emmerson Campbell (6 out of 42 patents)

4.  Una Campbell (6 out of 15 patents)

5.  Liming Shao (6 out of 38 patents)

6.  Philip Glyn Jones (6 out of 16 patents)

7.  Vadim Alexandrov (5 out of 5 patents)

8.  Michele L R Heffernan (5 out of 23 patents)

9.  Noel Aaron Powell (4 out of 15 patents)

10.  Carrie A Bowen (3 out of 5 patents)

11.  Michael Charles Hewitt (3 out of 33 patents)

12.  Kerry Leigh Spear (3 out of 29 patents)

13.  Lee W Herman (2 out of 3 patents)

14.  Douglas F Burdi (2 out of 5 patents)

15.  Sharon Rae Engel (1 out of 8 patents)


16 patents:

1. 11958862 - Compounds and compositions and uses thereof (2024-04-16),
2. 11491133 - Heteroaryl-isochroman compounds and uses thereof (2022-11-08),
3. 11332462 - Heteroaryl compounds and methods of use thereof (2022-05-17),
4. 11192885 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2021-12-07),
5. 11077090 - Compounds and compositions and uses thereof (2021-08-03),
6. 10927124 - Compounds and compositions and uses thereof (2021-02-23),
7. 10894033 - Multicyclic compounds and methods of use thereof (2021-01-19),
8. 10780074 - Compounds and uses thereof (2020-09-22),
9. 10556890 - Heteroaryl compounds and methods of use thereof (2020-02-11),
10. 10336732 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2019-07-02),
11. 10196403 - Compounds and compositions and uses thereof (2019-02-05),
12. 10189825 - Heteroaryl compounds and methods of use thereof (2019-01-29),
13. 10085968 - Multicyclic compounds and methods of use thereof (2018-10-02),
14. 9856238 - 1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders (2018-01-02),
15. 9758529 - Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders (2017-09-12),
Company Overview
Pgi Drug Discovery LLC, based in Paramus, NJ, specializes in the development of innovative therapeutic solutions aimed at addressing unmet medical needs. The company focuses on drug discovery and development processes, leveraging advanced technologies to enhance the efficacy and safety of pharmaceutical compounds. With a commitment to scientific excellence, Pgi Drug Discovery engages in research across various therapeutic areas, striving to bring novel treatments to market that improve patient outcomes and advance healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#8 in Paramus, NJ

#755 in New Jersey

#19,922 in US

#37,831 in the World

Paramus, NJ (US)
Paramus, NJ, United States of America

Pgi Drug Discovery LLC

Forward Citations = 41

17 inventors:

goldMedal Taleen G Hanania (14 out of 15 patents)

silverMedal Linghong Xie (8 out of 13 patents)

bronzeMedal John Emmerson Campbell (6 out of 42 patents)

4.  Una Campbell (6 out of 15 patents)

5.  Liming Shao (6 out of 38 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pgi Drug Discovery LLC. Retrieved from https://idiyas.com/company/pgi-drug-discovery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…